• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不可闭合卵圆孔未闭患者的长期临床结局

Long-term clinical outcomes for patients with uncrossable patent foramen ovale.

作者信息

Shin Yonghoon, Jang Albert Youngwoo, Won Yoonsun, Yang Taeil, Kim Joohan, Lee Joonpyo, Seo Jeongduk, Kim Minsu, Oh Pyung Chun, Chung Wook-Jin, Moon Jeonggeun, Kang Woong Chol

机构信息

Department of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Division of Cardiology, Department of Internal Medicine, Gil Medical Center, Gachon University, Incheon, Republic of Korea.

出版信息

Front Cardiovasc Med. 2023 Oct 13;10:1249259. doi: 10.3389/fcvm.2023.1249259. eCollection 2023.

DOI:10.3389/fcvm.2023.1249259
PMID:37900574
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10611517/
Abstract

INTRODUCTION

Patent foramen ovale (PFO) closure is performed in selected patients with cryptogenic stroke to prevent recurrence. The prognosis of patients with uncrossable PFO after failed guidewire or catheter passage during the procedure remains unknown. We compared the long-term prognosis between uncrossable PFO and successful PFO closure in patients with high-grade PFO shunts.

METHODS

We analyzed patients who underwent PFO closure for stroke or transient ischemic attack (TIA) prevention at Gachon University Gil Medical Center between April 2010 and March 2022. The primary outcome was a composite of recurrent stroke or TIA. Secondary outcomes included stroke, TIA, all-cause death, and a composite of stroke, TIA, and all-cause death.

RESULTS

Of 286 patients, 245 were included in the analysis after excluding those with transseptal puncture technique usage or concurrent atrial septal defect. Among them, 82 had uncrossable PFO, and 163 underwent successful PFO closure. Large shunts were more prevalent in the PFO closure group compared to the uncrossable PFO group (62.0% vs. 34.1%,  < 0.001), and resting shunts were also more common in the PFO closure group (17.8% vs. 2.4%,  < 0.001). Stroke or TIA occurred in 2 patients (2.4%) in the uncrossable PFO group and 8 patients (4.9%) in the PFO closure group (hazard ratio, 1.44; 95% confidence interval, 0.30-6.81;  = 0.647). Additionally, no disparities in the occurrence of stroke or TIA were found in subgroups divided by baseline characteristics, RoPE score, or shunt grade.

CONCLUSION

Clinical outcomes for patients with uncrossable PFO seem similar to those with successful PFO closure.

摘要

引言

对于部分不明原因卒中患者,会进行卵圆孔未闭(PFO)封堵术以预防复发。在手术过程中,导丝或导管无法通过的PFO患者的预后尚不清楚。我们比较了高度PFO分流患者中无法通过的PFO与成功进行PFO封堵的长期预后。

方法

我们分析了2010年4月至2022年3月期间在嘉泉大学吉尔医学中心因预防卒中或短暂性脑缺血发作(TIA)而接受PFO封堵术的患者。主要结局是复发性卒中或TIA的复合情况。次要结局包括卒中、TIA、全因死亡以及卒中、TIA和全因死亡的复合情况。

结果

在286例患者中,排除使用经房间隔穿刺技术或合并房间隔缺损的患者后,245例纳入分析。其中,82例PFO无法通过,163例成功进行了PFO封堵。与无法通过的PFO组相比,PFO封堵组中大量分流更为普遍(62.0%对34.1%,<0.001),静息分流在PFO封堵组中也更常见(17.8%对2.4%,<0.001)。无法通过的PFO组中有2例患者(2.4%)发生卒中或TIA,PFO封堵组中有8例患者(4.9%)发生(风险比,1.44;95%置信区间,0.30 - 6.81;P = 0.647)。此外,在按基线特征、RoPE评分或分流等级划分的亚组中,未发现卒中或TIA发生率存在差异。

结论

无法通过的PFO患者的临床结局似乎与成功进行PFO封堵的患者相似。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516f/10611517/8f8246c45fc2/fcvm-10-1249259-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516f/10611517/4df2b9990a85/fcvm-10-1249259-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516f/10611517/12d00ade647a/fcvm-10-1249259-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516f/10611517/57b9fff96924/fcvm-10-1249259-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516f/10611517/8f8246c45fc2/fcvm-10-1249259-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516f/10611517/4df2b9990a85/fcvm-10-1249259-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516f/10611517/12d00ade647a/fcvm-10-1249259-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516f/10611517/57b9fff96924/fcvm-10-1249259-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516f/10611517/8f8246c45fc2/fcvm-10-1249259-g004.jpg

相似文献

1
Long-term clinical outcomes for patients with uncrossable patent foramen ovale.不可闭合卵圆孔未闭患者的长期临床结局
Front Cardiovasc Med. 2023 Oct 13;10:1249259. doi: 10.3389/fcvm.2023.1249259. eCollection 2023.
2
Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.CLOSURE I(评价 STARFlex 间隔封堵系统在因推测性反常栓塞引起的脑卒中和/或短暂性脑缺血发作的卵圆孔未闭患者中的应用)试验中,不明原因卒中合并卵圆孔未闭患者复发性事件的预测因素。
JACC Cardiovasc Interv. 2014 Aug;7(8):913-20. doi: 10.1016/j.jcin.2014.01.170.
3
Residual Shunt After Patent Foramen Ovale Closure and Long-Term Stroke Recurrence: A Prospective Cohort Study.卵圆孔未闭封堵术后残余分流与长期卒中复发:一项前瞻性队列研究。
Ann Intern Med. 2020 Jun 2;172(11):717-725. doi: 10.7326/M19-3583. Epub 2020 May 12.
4
Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.卵圆孔未闭患者隐源性卒中和短暂性脑缺血发作后再发脑血管事件的风险:FORI(意大利卵圆孔未闭登记研究)。
Cerebrovasc Dis. 2011;31(2):109-16. doi: 10.1159/000321334. Epub 2010 Nov 17.
5
Prognosis of Cryptogenic Stroke With Patent Foramen Ovale at Older Ages and Implications for Trials: A Population-Based Study and Systematic Review.高龄卵圆孔未闭不明原因卒中的预后及临床试验的意义:基于人群的研究和系统综述。
JAMA Neurol. 2020 Oct 1;77(10):1279-1287. doi: 10.1001/jamaneurol.2020.1948.
6
Percutaneous Closure of Patent Foramen Ovale in Patients with Cryptogenic Stroke - An Updated Comprehensive Meta-Analysis.不明原因卒中患者卵圆孔未闭的经皮封堵术——一项更新的综合荟萃分析
Cardiovasc Revasc Med. 2019 Aug;20(8):687-694. doi: 10.1016/j.carrev.2018.09.010. Epub 2018 Sep 19.
7
Device Closure or Antithrombotic Therapy After Cryptogenic Stroke in Elderly Patients With a High-Risk Patent Foramen Ovale.老年高危卵圆孔未闭患者隐源性卒中后的封堵装置治疗或抗栓治疗
J Stroke. 2024 May;26(2):242-251. doi: 10.5853/jos.2023.03265. Epub 2024 May 30.
8
Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack.卵圆孔未闭且有隐源性卒中或短暂性脑缺血发作病史患者预防复发性卒中的封堵治疗与药物治疗对比
Cochrane Database Syst Rev. 2015 Sep 8;2015(9):CD009938. doi: 10.1002/14651858.CD009938.pub2.
9
Multidisciplinary assessment of PFO with substantial right-to-left shunting and medium-term follow-up after PFO device closure: A single-center experience.伴有大量右向左分流的卵圆孔未闭的多学科评估及卵圆孔未闭封堵术后的中期随访:单中心经验
J Interv Cardiol. 2017 Aug;30(4):362-367. doi: 10.1111/joic.12396. Epub 2017 Jun 1.
10
Intermediate and long-term results of transcatheter closure of patent foramen ovale using the amplatzer patent foramen ovale occluder: one case of pulmonary embolism irrespective of patent foramen ovale closure.经导管卵圆孔未闭封堵术应用 Amplatzer 卵圆孔未闭封堵器的中远期结果:1 例肺栓塞与卵圆孔未闭封堵无关。
Korean Circ J. 2011 Jul;41(7):356-62. doi: 10.4070/kcj.2011.41.7.356. Epub 2011 Jul 30.

引用本文的文献

1
The detailed transseptal puncture technique for optimal closure in patients with a patent foramen ovale.卵圆孔未闭患者实现最佳封堵的详细经间隔穿刺技术。
Front Cardiovasc Med. 2024 Nov 29;11:1453459. doi: 10.3389/fcvm.2024.1453459. eCollection 2024.

本文引用的文献

1
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association.《2021年卒中与短暂性脑缺血发作患者卒中预防指南:美国心脏协会/美国卒中协会指南》
Stroke. 2021 Jul;52(7):e364-e467. doi: 10.1161/STR.0000000000000375. Epub 2021 May 24.
2
Cryptogenic Stroke and High-Risk Patent Foramen Ovale: The DEFENSE-PFO Trial.隐源性卒中与高风险卵圆孔未闭:DEFENSE-PFO 试验。
J Am Coll Cardiol. 2018 May 22;71(20):2335-2342. doi: 10.1016/j.jacc.2018.02.046. Epub 2018 Mar 12.
3
Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke.
卵圆孔未闭封堵与卒中后抗凝或抗血小板治疗的比较
N Engl J Med. 2017 Sep 14;377(11):1011-1021. doi: 10.1056/NEJMoa1705915.
4
Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke.卵圆孔未闭封堵或卒中后药物治疗的长期结局。
N Engl J Med. 2017 Sep 14;377(11):1022-1032. doi: 10.1056/NEJMoa1610057.
5
Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke.卵圆孔未闭封堵或抗血小板治疗不明原因卒中。
N Engl J Med. 2017 Sep 14;377(11):1033-1042. doi: 10.1056/NEJMoa1707404.
6
Effect of patent foramen ovale closure for prevention on recurrent stroke or transient ischemic attack in selected patients with cryptogenic stroke.卵圆孔未闭封堵术对特定不明原因卒中患者预防复发性卒中或短暂性脑缺血发作的效果。
J Interv Cardiol. 2018 Jun;31(3):368-374. doi: 10.1111/joic.12430. Epub 2017 Aug 21.
7
Comparison of Outcomes after Device Closure with Transseptal Puncture and Standard Technique in Patients with Patent Foramen Ovale and Ischemic Events.卵圆孔未闭与缺血性事件患者经房间隔穿刺封堵术与标准技术封堵术后结局的比较
J Interv Cardiol. 2016 Aug;29(4):400-5. doi: 10.1111/joic.12296. Epub 2016 Jun 10.
8
Comparison of Outcomes after Device Closure and Medication Alone in Patients with Patent Foramen Ovale and Cryptogenic Stroke in Korean Population.韩国人群中卵圆孔未闭合并隐匿性卒中患者经装置封堵与单纯药物治疗后的结局比较
Yonsei Med J. 2016 May;57(3):621-5. doi: 10.3349/ymj.2016.57.3.621.
9
Transseptal puncture to facilitate device closure of "long-tunnel" patent foramen ovale.经房间隔穿刺以促进“长隧道”型卵圆孔未闭的器械封堵。
Catheter Cardiovasc Interv. 2015 May;85(6):1053-7. doi: 10.1002/ccd.25723. Epub 2014 Nov 21.
10
Echocardiographic findings in simple and complex patent foramen ovale before and after transcatheter closure.经导管封堵前后单纯及复杂房间隔缺损患者的超声心动图表现。
Eur Heart J Cardiovasc Imaging. 2014 Dec;15(12):1377-85. doi: 10.1093/ehjci/jeu143. Epub 2014 Aug 19.